TipRanks
Advertisement
Advertisement

CYTK Stock Latest News

Cytokinetics announces results from ACACIA-HCM, MAPLE-HCM
The FlyCytokinetics announces results from ACACIA-HCM, MAPLE-HCM
19d ago
CYTK
Cytokinetics Reports Positive Phase 3 Aficamten HCM Results
PremiumCompany Announcements
Cytokinetics Reports Positive Phase 3 Aficamten HCM Results
21d ago
8K
CYTK
Morning Movers: PayPal sinks after report says Advent, Stripe lost interest
PremiumThe Fly
Morning Movers: PayPal sinks after report says Advent, Stripe lost interest
21d ago
CHA
GAP
Cytokinetics reports ACACIA-HCM trial met both primary endpoints
PremiumThe Fly
Cytokinetics reports ACACIA-HCM trial met both primary endpoints
21d ago
CYTK
Cytokinetics Earnings Call Highlights MYQORZO Surge
PremiumCompany Announcements
Cytokinetics Earnings Call Highlights MYQORZO Surge
1M ago
CYTK
Hold Rating Reaffirmed as Patent Dispute Adds Risk; $85 Price Target Remains Unchanged
PremiumRatingsHold Rating Reaffirmed as Patent Dispute Adds Risk; $85 Price Target Remains Unchanged
1M ago
CYTK
Cytokinetics price target raised to $110 from $95 at Barclays
Premium
The Fly
Cytokinetics price target raised to $110 from $95 at Barclays
1M ago
CYTK
Cytokinetics price target raised to $103 from $97 at JPMorgan
Premium
The Fly
Cytokinetics price target raised to $103 from $97 at JPMorgan
1M ago
CYTK
Cytokinetics Files Patent Suit to Protect MYQORZO Franchise
PremiumCompany Announcements
Cytokinetics Files Patent Suit to Protect MYQORZO Franchise
1M ago
8K
CYTK
Cytokinetics price target raised to $112 from $106 at Truist
PremiumThe Fly
Cytokinetics price target raised to $112 from $106 at Truist
1M ago
CYTK
Cytokinetics price target raised to $85 from $83 at BofA
PremiumThe Fly
Cytokinetics price target raised to $85 from $83 at BofA
1M ago
CYTK
Cytokinetics price target raised to $112 from $102 at Needham
PremiumThe Fly
Cytokinetics price target raised to $112 from $102 at Needham
1M ago
CYTK
Cytokinetics price target lowered to $112 from $117 at RBC Capital
PremiumThe FlyCytokinetics price target lowered to $112 from $117 at RBC Capital
1M ago
CYTK
Cytokinetics: Strong MYQORZO Launch and Upcoming Catalysts Support Buy Rating and Unchanged $140 Price Target
Premium
Ratings
Cytokinetics: Strong MYQORZO Launch and Upcoming Catalysts Support Buy Rating and Unchanged $140 Price Target
1M ago
CYTK
Cytokinetics price target raised to $110 from $105 at Citizens
Premium
The Fly
Cytokinetics price target raised to $110 from $105 at Citizens
1M ago
CYTK
Cytokinetics reports Q2 EPS ($1.50), consensus ($1.60)
PremiumThe Fly
Cytokinetics reports Q2 EPS ($1.50), consensus ($1.60)
1M ago
CYTK
Cytokinetics (CYTK) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Cytokinetics (CYTK) Q2 Earnings Cheat Sheet
2M ago
CYTK
Opus, Cytokinetics, Albertsons, Weatherford, Paysign Shock
PremiumWeekend Updates
Opus, Cytokinetics, Albertsons, Weatherford, Paysign Shock
2M ago
ACI
IRD
Cytokinetics announces MHRA authorization for Myqorzo
PremiumThe Fly
Cytokinetics announces MHRA authorization for Myqorzo
2M ago
CYTK
Travelers, TransDigm, Cytokinetics, Global-e, Crescent Shock Moves
PremiumWeekend UpdatesTravelers, TransDigm, Cytokinetics, Global-e, Crescent Shock Moves
2M ago
TDG
TRV
Larimar, Cytokinetics, Itau, Global-e, Immunovant Shake-Up
Premium
Weekend Updates
Larimar, Cytokinetics, Itau, Global-e, Immunovant Shake-Up
2M ago
CYTK
GLBE
Cytokinetics price target lowered to $117 from $119 at RBC Capital
Premium
The Fly
Cytokinetics price target lowered to $117 from $119 at RBC Capital
2M ago
CYTK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >